Special Issue "Bacteriophages-Based Technologies for a One Health Society: Applications in Clinical, Veterinary, and Industrial Settings"
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 10666
Interests: bacteriophage; antibiotic resistance; synthetic biology; biofilms
An alarming escalating rise in global multi-drug resistant bacteria presents a huge environmental, social and economic burden. Suitable alternatives to traditional antibiotic treatments are now being sought in a range of settings. Bacteriophages (phages for short) are viruses that target, infect and kill bacteria. Phage therapy has been a much under-explored alternative to antibiotic use, but a renaissance in phage-based therapies is now highly anticipated.
This Microorganisms research topic will offer deep insights into the latest developments of research dedicated to bacteriophage therapy, consistent with a ‘One Health’ approach, providing potential alternative solutions to treating bacterial pathogens with phages.
This Special Issue topic will appeal to, and provide a platform for, researchers interested in the potential for phage therapy to share their recent results in a variety of environments, including clinical settings, veterinary medicine, and industrial applications, such as food and beverage industries. Research relating to phage therapy in farming practices, namely agriculture and aquaculture, is also very much welcomed. These findings will provide a foundation to enlarge the current application of phage therapies in the treatment of recalcitrant pathogenic bacteria.
We look forward to assembling an issue that highlights some of the best current research in applications for phage therapy across diverse environments.
Dr. Karen D. Weynberg
Dr. Sabrina Green
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antibiotic resistance
- bacteriophage therapy
- One Health